Fetuin A test to predict kidney function decline
Part of Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at a blood protein called fetuin A to see if it can forecast worsening kidney function over time in people with treated high blood pressure. It may help identify who is at higher risk for kidney decline so care can be adjusted earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high blood pressure and are taking at least one blood pressure medicine
- You do not have diabetes (including based on recent blood sugar or HbA1c results)
- Your blood pressure is not very uncontrolled (not around 180/110 or higher in clinic or on 24-hour monitoring)
- You are not on dialysis or any kidney replacement therapy
- You do not currently have active severe illness from the listed conditions, such as ongoing acute infection
- You do not have major liver disease or a terminal, incurable illness
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new markers in blood or urine that may help explain heart (cardiovascular) risk in people with chronic kidney disease. It may help doctors better predict risk, especially in those not yet on dialysis.
This study looks at whether high uric acid levels can hint at early kidney problems in people with prediabetes. It involves a blood test and follow-up over time to check kidney health.
This study looks at FGF19 to see if it can improve chronic kidney disease in people who do not have diabetes. Participants may receive FGF19 (and may need extra testing such as muscle biopsies).
This study looks at whether certain proteins in the urine (albumin) can help predict if a person with acute heart failure will develop sudden kidney injury while in the ICU. It aims to find early warning signs to improve care.
This study looks at two simple blood tests (neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio) to see if they can help predict how chronic kidney disease (CKD) will progress over time. It aims to find new ways to monitor your kidney health.
This study checks whether a set of blood and urine tests can predict “acute kidney injury” (a sudden worsening of kidney function) earlier in people with diabetes who are undergoing a heart procedure. If the tests work, they may help doctors spot kidney trouble sooner and protect your kidneys.
Hear when a new Arterial Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.